×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Drawing the Boundaries of Data Disclosure in Clinical Trials
Session Chair(s)
Marie Manley
Partner, Head of EU and UK Life Sciences (UK)
Sidley Austin LLP, United Kingdom
Drawing the Boundaries of Data Disclosure in Clinical Trials
Learning Objective : - Discuss the main changes introduced by the Clinical Trials Regulation; - Explain the perceived impact of the EU portal and database on clinical trials in the EU; and - Evaluate the amendments in the Clinical Trials Regulation and in particular the impact on transparency
Speaker(s)
Marie Manley
Sidley Austin LLP, United Kingdom
Partner, Head of EU and UK Life Sciences (UK)
Further Issues and Priorities to Be Solved
Sini Eskola, MPharm, MS, MSc
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Director Regulatory Strategy
Have an account?